The Mortality Improvement Model, MIM-2021-v2
Longevity Advisory Group
Larry N. Stern, Chair, FSA, MAAA
Jean-Marc Fix, FSA, MAAA
Sam Gutterman, FSA, MAAA, CERA, FCAS, FCA, HonFIA
R. Dale Hall, FSA, MAAA, CERA, CFA
Thomas A. Jones, ASA, MAAA
Allen M. Klein, FSA, MAAA
Patrick David Nolan, FSA, MAAA
Laurence Pinzur, Ph.D.
Ronora Stryker, ASA, MAAA
Patrick Wiese, ASA
Research Insights - The Mortality Improvement Model, MIM-2021
Table of Contents
Different mortality projection methodologies are utilized by actuaries across applications and practice areas. As a result, the SOA’s Longevity Advisory Group (“Advisory Group”) developed a single framework to serve as a consistent base for practitioners in projecting mortality improvement. The Mortality Improvement Model, MIM-2021-v2, Tools and User Guides, compose the consistent approach and are defined below.
- A report describing MIM-2021-v2 which summarizes the evolution of MIM-2021-v2; provides an overview of MIM-2021-v2; presents considerations for applying mortality assumptions in the model; and outlines issues the Advisory Group is currently considering for future model enhancements.
- An Excel-based tool, MIM-2021-v2 Application Tool, and user guide, MIM-2021-v2 Application Tool User Guide, for practitioners to construct sets of mortality improvement rates under this framework for specific applications.
- An Excel-based tool, MIM-2021-v2 Data Analysis Tool, and user guide, MIM-2021-v2 Data Analysis Tool User Guide, for practitioners to analyze the historical data sets included in the MIM-2021-v2 Application Tool.
The Longevity Advisory Group is planning to update the framework annually as new data and enhancements become available. MIM-2021-v2 is the first revision since the initial release in April 2021. This version uses the same underpinning as the initial MIM-2021 release but has been refreshed to include another year of historical U.S. population mortality data as well as more user flexibility and functionality to replicate RPEC’s MP-2021 and O2-2021 scales.
Report, User Guides, and OpEd
OpEd: The Layers of Mortality Improvement – R. Dale Hall, FSA, MAAA, CERA, CFA
The Society of Actuaries Research Institute does not warrant these tools as fit for use in any respect, and no warranty whatsoever should be assumed or implied by any individual of this product or its fitness for any particular purpose. Actuaries, insurers, regulators and other parties use this tool at their own risk. The Institute disclaims all responsibility for any party’s use or misuse of its tools and for any work product generated through use or misuse of the tools.
By accepting, I acknowledge that I have read and understand the above disclaimer language. (User needs to accept before downloading one or both tools).
Mary Bahna-Nolan, FSA, MAAA, CERA
James Berberian, ASA, EA, MAAA, FCA
Kevin Mark Bye Jr, ASA
Timothy D. Morant, FSA, MAAA
Marianne Purushotham, FSA, MAAA
Linn K. Richardson, FSA, MAAA, CERA
Manuel S. Santos, FSA, FCIA
George Silos, FSA, MAAA, CERA
Joel C. Sklar, ASA, MAAA
Jim Toole, FSA, MAAA, CERA
At the Society of Actuaries:
Jan Schuh, Sr. Research Administrator
Questions or Comments?
Give us your feedback! Take a short survey on this report. Take Survey
If you have comments or questions, please send an email to firstname.lastname@example.org.